WallStreetZenWallStreetZen

NYSE: COR
Cencora Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cencora earnings were $1.9B for the trailing 12 months ending Jun 30, 2025, with 5.4% growth year over year. The latest COR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $687.4M, down 4.2% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, COR reported annual earnings of $1.5B, with -13.5% growth. The next COR earnings date is Nov 12, 2025.

COR past earnings growth

How has COR's earnings growth performed historically?

Company
5.37%
Industry
23.96%
Market
34.06%
COR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
COR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
COR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

COR earnings history

Current Revenue
$316.7B
Current Earnings
$1.9B
Current Profit Margin
0.6%

COR Return on Equity

Current Company
196.3%
Current Industry
-11.1%
Current Market
30.7%
COR's Return on Equity (196.3%)... subscribe to Premium to read more.
High Return on Equity Performance

COR undefined

Current Company
2.7%
Current Industry
3.4%
COR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when COR announces earnings.

COR undefined

Current Company
13.97%
Current Industry
19.2%
COR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COR vs Medical Distribution Stocks

TickerEBITDAEarningsY/Y EarningsEPS
COR$3.27B$1.90B+5.15%$9.81
CAH$3.10B$1.56B+32.70%$6.48
MCK$5.26B$3.16B+35.85%$25.12
HSIC$959.00M$389.00M-4.87%$3.14
AHG-$163.73M-$134.98MN/A-$0.48
View Top Medical Distribution Stocks

COR earnings dates

Next earnings date
Nov 12, 2025

Cencora Earnings Reports & History FAQ

What were Cencora's earnings last quarter?

On COR's earnings call on Invalid Date, Cencora (NYSE: COR) reported Q2 2025 earnings per share (EPS) of $3.55, up 45.49% year over year. Total COR earnings for the quarter were $687.40 million. In the same quarter last year, Cencora's earnings per share (EPS) was $2.44.

If you're new to stock investing, here's how to buy Cencora stock.

When does Cencora report earnings?

The next COR earnings date is Invalid Date. Add COR to your watchlist to be reminded of Cencora's next earnings date.

Is Cencora profitable or losing money?

As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $1.90 billion, a 2.21% increase year over year.

What was COR's earnings growth in the past year?

As of Cencora's earnings date in Invalid Date, Cencora's earnings has grown 5.37% year over year. This is 18.59 percentage points lower than the US Medical Distribution industry earnings growth rate of 23.96%. COR earnings in the past year totalled $1.90 billion.

What are Cencora's earnings expectations?

The current EPS estimate for Cencora's earnings report in Invalid Date is $3.82.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.